School of Medicine
Showing 21-29 of 29 Results
Dr. Michael T. Longaker
Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Current Research and Scholarly InterestsWe have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.
H. Peter Lorenz, MD
Professor of Surgery (Plastic and Reconstructive Surgery)
Current Research and Scholarly InterestsWe have three areas of current investigation:
1) Scarless skin wound healing biology
2) Dot stem cell tissue regeneration biology
3) Novel stem cell therapy for tissue engineering
Associate Dean of the Faculty for Maternal and Child Health and Elizabeth Wood Dunlevie Professor
BioDr. Lund was born in Duluth, MN and attended Harvard College and Harvard Medical School. He received his general surgical training at the MGH in Boston, and his pediatric surgical training at Boston Children's Hospital. His initial career was spent as a trauma, transplant and general pediatric surgeon at Boston Children's. In 1999, he became Surgeon-in-Chief of the University of Wisconsin Children's Hospital in in Madison, and in 2001 became Chair of General Surgery at the University of Wisconsin-Madison. In 2011, he became Executive Vice President of the Phoenix Children's Medical Group and Surgeon-in-Chief at Phoenix Children's Hospital. Dr. Lund joined the Stanford faculty in Pediatric Surgery and as Associate Dean of the Faculty in Pediatrics and Obstetrics (Clinical Affairs) as well as Chief Medical Officer at Lucile Packard Children's Hospital in March, 2015. In March of 2018 and through January of 2019, Dr. Lund served as interim President and CEO of Lucile Packard Children's Hospital.
Daphne P. Ly, MD, FACS
Current Research and Scholarly Interests1. Integrate machine learning with electronic health record system to improve work flow and achieve individualize cancer care based on current evidence.
2. Apply Cancer Genetics in cancer treatment and cancer risk reduction.